|
Michael F. Adams, President & CEO was appointed to his current position in August 2006. A longtime member of the board of directors, Mr. Adams rejoined CardioTech's management team in April to direct all regulatory clinical and quality activities, responsibilities that are part of his current position. As CardioTech's Vice President of Regulatory Affairs and Business Development from 1998 to 2000, he obtained CE Mark approval for a complete line of implantable prosthetic vascular grafts. Prior to rejoining CardioTech, Mr. Adams was Vice President of New Ventures at PLC Medical Systems, a medical device and therapy company. Earlier experience in regulatory affairs and quality assurance include management positions at CR Bard and Millipore Corporation. Mr. Adams began his career at Dupont after earning a Bachelor of Science in Applied Chemistry from the University of Massachusetts. He received his certification in Regulatory Affairs (RAC) in 1991. | 